Page breadcrumb nav

VAERS Report 2156900

Case Report Section

Vaer Report Details

Age: NA

Gender: Female

State: Outside US

Patient Died?
No
Vaccine information

Name: COVID19 (COVID19 (PFIZER-BIONTECH))

Type: Coronavirus 2019 vaccine

Manufacturer: PFIZER

Lot: unknown


Date report was received
2022-03-04
Date form completed
Date Vaccinated
2021-11-28
Date of Onset
0
Number of days (onset date – vaccination date)
0
Adverse Event Description

pain in ankles/pain in knees/joints too painful; pain in hands; nodules have appeared in fingers; swelling in left ankle joint; affecting movement and ability at gym; arthritis flare up; primary immunisation: non-pfizer vaccine; booster: comirnaty; primary immunisation: non-pfizer vaccine; booster: comirnaty; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency (ra). the reporter is the patient. regulatory number: gb-mhra-webcovid-202202241614467220-ksq4u (ra). other case identifier(s): gb-mhra-adr 26652637 (ra). a 53 year-old female patient (not pregnant) received bnt162b2 (comirnaty), administration date 28nov2021 (batch/lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "breathlessness" (unspecified if ongoing); "fatigue" (unspecified if ongoing); "rheumatoid arthritis" (unspecified if ongoing), notes: taking regular medicines for rheumatoid arthritis (or other types of arthritis except osteoarthritis); "suspected covid-19", start date: 12mar2020, stop date: 17mar2020, notes: at the very start of the pandemic prior to vaccinations&recording, and left patient fatigued and breathless that became worse requiring intervention with inhalers; "asthmatic" (unspecified if ongoing), notes: became asthmatic last year. the patient's concomitant medications were not reported. past drug history included: salbutamol for asthma, notes: when required; fostair for asthma, notes: am and pm. vaccination history included: covid-19 vaccine (dose 2, manufacturer unknown), for covid-19 immunisation; covid-19 vaccine (dose 1, manufacturer unknown), for covid-19 immunisation. the following information was reported: off label use (medically significant), interchange of vaccine products (medically significant) all with onset 28nov2021, outcome "unknown" and all described as "primary immunisation: non-pfizer vaccine; booster: comirnaty"; arthritis (medically significant) with onset 29nov2021, outcome "recovered with sequelae", described as "arthritis flare up"; arthralgia (medically significant), outcome "unknown", described as "pain in ankles/pain in knees/joints too painful"; pain in extremity (medically significant), outcome "unknown", described as "pain in hands"; nodule (medically significant), outcome "unknown", described as "nodules have appeared in fingers"; joint swelling (medically significant), outcome "unknown", described as "swelling in left ankle joint"; hypokinesia (medically significant), outcome "unknown", described as "affecting movement and ability at gym". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (08aug2020) no - negative covid-19 test. therapeutic measures were taken as a result of arthritis, arthralgia, pain in extremity, nodule, joint swelling, hypokinesia. the clinical course was reported as follows: the patient increased anti-inflammatories (manufacturer unknown) temporarily but the pain had continued especially in ankles, knees and hands. nodules had appeared in fingers and swelling in left ankle joint was affecting the movement and ability at gym, she had regressed to where she was at pre booster as joints were too painful. it was reported that the patient had requested blood tests as there was no sign of reduction and then a review of meds and possible further referrals. the patient was not pregnant and was not breastfeeding at the time of this report. the last menstrual period date of the patient was 05nov2020. the patient was not enrolled in clinical trial. the patient had not been tested positive for covid-19 since having the vaccine. the report was not related to possible inflammation of the heart (myocarditis or pericarditis). no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Lab Data
test date: 20200808; test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test
List of symptoms
arthritis arthralgia hypokinesia pain in extremity joint swelling nodule interchange of vaccine products sars-cov-2 test off label use
Patient Died?
No
Date Died
NA
Birth defect
false
Vaccine Administered By:
Other
Vaccine Purchased By:
Unknown
Patient visit ER?
No
Patient Hospitalized?
No
Stay in hospital
No
Days in hospital
Unspecified
Permanent disability?
No
Allergies:
na
Current Illness
na